119 related articles for article (PubMed ID: 37620987)
1. Efficacy of sesame oil versus placebo in the management of acute radiation-induced dermatitis in breast cancer patients: A double-blind randomized clinical trial.
Moslemi D; Ramezany S; Moghadamnia AA; Ebrahimian S
Asia Pac J Clin Oncol; 2023 Dec; 19(6):747-751. PubMed ID: 37620987
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
[TBL] [Abstract][Full Text] [Related]
3. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
Boström A; Lindman H; Swartling C; Berne B; Bergh J
Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
[TBL] [Abstract][Full Text] [Related]
4. Recove® burn ointment for managing acute radiodermatitis in patients with breast cancer: A double blind randomized controlled trial.
Abbaszade Marzbali N; Zabihi E; Vallard A; Magne N; Moslemi M; Moslemi D
Caspian J Intern Med; 2022; 13(2):349-355. PubMed ID: 35919651
[TBL] [Abstract][Full Text] [Related]
5. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
[TBL] [Abstract][Full Text] [Related]
6. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
7. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
8. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
9. Topical Ectoin Versus Topical Dexpanthenol for Managing Acute Radiodermatitis Associated With Breast Cancer Radiotherapy: A Randomized Double-Blind Study.
Abd Elazim NE; Awad SM; El-Naggar MS; Mohamed RH
Dermatitis; 2023; 34(6):516-524. PubMed ID: 37792331
[No Abstract] [Full Text] [Related]
10. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
11. Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.
Sekiguchi K; Ogita M; Akahane K; Haga C; Ito R; Arai S; Ishida Y; Tsukada Y; Kawamori J
Jpn J Clin Oncol; 2015 Dec; 45(12):1146-53. PubMed ID: 26491204
[TBL] [Abstract][Full Text] [Related]
12. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial.
Ben-David MA; Elkayam R; Gelernter I; Pfeffer RM
Isr Med Assoc J; 2016; 18(3-4):188-92. PubMed ID: 27228641
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial.
Shariati L; Amouheidari A; Naji Esfahani H; Abed A; Haghjooy Javanmard S; Laher I; Ghasemi A; Vaseghi G
Br J Clin Pharmacol; 2020 Sep; 86(9):1875-1881. PubMed ID: 32040868
[TBL] [Abstract][Full Text] [Related]
14. Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.
Talakesh T; Tabatabaee N; Atoof F; Aliasgharzadeh A; Sarvizade M; Farhood B; Najafi M
Curr Radiopharm; 2022; 15(4):332-340. PubMed ID: 35747962
[TBL] [Abstract][Full Text] [Related]
15. Effect of melatonin cream on acute radiation dermatitis in patients with primary breast cancer: A double-blind, randomized, placebo-controlled trial.
Zetner D; Kamby C; Christophersen C; Gülen S; Paulsen CB; Piga E; Hoffmeyer B; Mahmood F; Rosenberg J
J Pineal Res; 2023 Aug; 75(1):e12873. PubMed ID: 37055944
[TBL] [Abstract][Full Text] [Related]
16. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial.
Maillot O; Leduc N; Atallah V; Escarmant P; Petit A; Belhomme S; Sargos P; Vinh-Hung V
Cancer Radiother; 2018 May; 22(3):205-210. PubMed ID: 29678596
[TBL] [Abstract][Full Text] [Related]
18. The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Sahin F; Pirouzpanah MB; Bijanpour H; Mohammadzadeh M; Eghdam Zamiri R; Ghasemi Jangjoo A; Nasiri B; Saboori H; Doğan A; Demirci S; Ayşan E; Çağrı Büke A; Naseri AR; Shakouri SK; Aghamohammadi D; Alizade-Harakiyan M; Seyed Nejad F
Oncol Res Treat; 2022; 45(4):197-204. PubMed ID: 34979503
[TBL] [Abstract][Full Text] [Related]
19. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
20. A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy.
Long X; Guo J; Yin Y; Cheng M; Zhang X; Zhang J; Wang P; Zang J; Zhao L
Radiat Oncol; 2023 Oct; 18(1):174. PubMed ID: 37891689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
